Osteogenesis imperfect (OI) is a rare genetic disease of connective tissue, the main manifestation are fractures that are developing due to increased bone fragility in both children and adults. Currently, it is known that the genetic basis of the disease in 90% of cases are violations in the genes COL1A1 and COL1A2. Diagnosis of this disease is mostly based on clinical and radiological data; some laboratory parameters of blood and urine can provide additional information but, due to the low specificity, these tests are not widely used in clinical practice when diagnosing the bone pathology. Separate extensive problem is the realization of timely differential diagnosis followed by the establishment of correct diagnosis and development of the right tactics. Currently, the standard of management of patients with OI is a multidisciplinary approach that allows to perform the necessary examination of a child, to make an accurate diagnosis, and start the therapy in time. A practitioneer should have sufficient knowledge about the disease and be able to apply it practically to realize the treatment tactics.
CITATION STYLE
Ignatovich, O. N., Namazova-Baranova, L. S., Мargieva, Т. V., Yakhyaeva, G. Т., Zhurkova, N. V., Savostyanov, К. V., … Krotov, I. A. (2018). Osteogenesis Imperfecta: Diagnostic Feature. Pediatric Pharmacology, 15(3), 224–232. https://doi.org/10.15690/pf.v15i3.1902
Mendeley helps you to discover research relevant for your work.